Hungarian prime minister Viktor Orban has decreed that the creation of a vast pro-government media conglomerate cannot be challenged by competition authorities, fueling fresh fears for the country’s press freedom and rule of law.
Last week, the owners of some 480 newspapers, magazines, broadcasters, and websites announced they were “donating” them to the Central European Press and Media Foundation, which is run by close Orban ally Gabor Liszkay and includes current and former members of the ruling Fidesz party on its board.
On Wednesday, December 5, Mr Orban signed a decree to shield the foundation from Hungary’s media and competition watchdogs, by declaring the merger to be an event of “national strategic importance” that serves “the public interest of saving print media.”
Gabor Polyak, analyst at Hungarian media think tank Mertek, said competition was being distorted by the conglomerate.
“The fact the government opted for this political solution is an open admission this would not have passed the provisions of either the media law or the competition law,” he said. “This will create a scale of media concentration unthinkable in the Western world.”
Full Content: Reuters
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Top Antitrust Expert Joins Cravath from Paul Weiss
Jan 21, 2025 by
CPI
CMA Chief Removed as UK Government Targets Regulatory Overhaul
Jan 21, 2025 by
CPI
Court Denies Dismissal in Crab Price-Fixing Lawsuit
Jan 21, 2025 by
CPI
TikTok Stays Online for Now: Trump Floats US Ownership Deal
Jan 21, 2025 by
CPI
Hong Kong Watchdog Unveils Compliance Tool for Small Businesses
Jan 21, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Pharmacy Benefit Managers
Jan 20, 2025 by
CPI
Untangling the PBM Mess
Jan 20, 2025 by
Kent Bernard
Using Data, Not Anecdotes, to Analyze Criticisms of Pharmacy Benefit Managers
Jan 20, 2025 by
Dennis Carlton
Vertical Integration and PBMs: What, Me Worry?
Jan 20, 2025 by
Lawton Robert Burns & Bradley Fluegel
The Economics of Benefit Management in Prescription-Drug Markets
Jan 20, 2025 by
Casey B. Mulligan